A study on tolerance and influencing factors of early enteral nutritional support in post-operative patients with esophageal cancer

韩超,赵艺媛,陶立燕,段宏伟,杜松涛,董潇,韩颖,薛丽丽,唐冲

DOI: https://doi.org/10.3969/j.issn.1008-9691.2015.03.019

2015-01-01

Abstract:Objective To explore the tolerance and influencing factors of early enteral nutritional (EN) support in post-operative patients with esophageal cancer.Methods A retrospective study was conducted. 107 patients with esophagus cancer after radical esophagectomy hospitalized in the Cancer Hospital of Peking University from September 2012 to July 2014 were enrolled. They received 500 mL drinking water at the speed of 20 mL/h through jejunal nutritional tube on the first day after surgery. On the second day after operation, a nutritional emulsion was pumped into intestine through jejunal nutritional tube with an initial amount different in quantity 200,400 or 500 mL. The patients' gender, age (> 4 years and < 60 years), the situation of intolerance toward the enteral nutrition at early stage and its method of management, initial EN dose at early stage and the influence of time necessary to achieve the target total amount on tolerance were investigated.Results 107 patients began to receive EN on the mean (2.32±0.71) days at early stage after surgery, and passing the mean (5.47±2.57) days the target amount could be reached. Abdominal distension or diarrhea occurred in 41.1% (44 cases) of patients, 11.2% (12 cases) of whom suffered from both abdominal distension and diarrhea. The mean time of abdominal distension onset was 5 (3, 7) days, and that of diarrhea onset was 7 (4, 10) days. Nine patients (8.7%) stopped the early EN because of the intolerance toward abdominal pain or diarrhea. The factors of influences on the incidence of intolerance toward EN having no statistically significant differences (allP > 0.05) were as follows: gender, the proportion of male versus female [41.1% (37/90) vs. 41.2% (7/17)], ages < 60 years versus > 60 years [37.9% (25/66) vs. 46.3% (19/41)] and different times to achieve target total amount < 4 days versus > 4 days [42.6% (23/54) vs. 39.6% (21/53)]. Along with the increase of the initial amounts (200, 400, 500 mL), the incidence of patients' intolerance had no statistically significant difference (P > 0.05), though a tendency of increase in incidence was seen [33.3% (11/33), 40.4% (11/27), 46.8% (22/47) respectively].Conclusions The majority of post-operative patients with esophagus cancer may endure EN support in the early stage, while those having experienced intolerance may be relieved basically after treatment; shortening the time to achieve target amount of EN support has no effect on the incidence of intolerance.